Literature DB >> 17722048

Muscle membrane excitability after exercise in thyrotoxic periodic paralysis and thyrotoxicosis without periodic paralysis.

Kimiyoshi Arimura1, Yumiko Arimura, Arlene R Ng, Shun-Ichi Sakoda, Itsuro Higuchi.   

Abstract

We evaluated whether the paralytic attacks in thyrotoxic periodic paralysis (TPP) are primarily due to the abnormal excitability of the muscle membrane caused by a preexisting latent abnormality or to the effects of thyroid hormone. The prolonged exercise (PE) test was used to evaluate muscle membrane excitability in 21 patients with TPP and 11 patients with thyrotoxicosis without paralytic attacks (Tw/oPP) in the hyperthyroid state. The PE tests were compared between the hyperthyroid and euthyroid states in five of the TPP and three of the Tw/oPP patients. Compared to 20 healthy subjects, a significant increase in compound muscle action potential (CMAP) amplitudes immediately after exercise and a significant time-dependent gradual decline in CMAP amplitudes starting from 20 min after exercise were observed in the TPP patients. A significant decline in CMAP amplitudes was also observed in the Tw/oPP patients but only at 50 min after exercise. All of the TPP and Tw/oPP patients had a tendency to improve in the euthyroid state; the PE tests remained abnormal only in the TPP patients. Paralytic attacks in TPP patients are due primarily to a preexisting latent abnormal excitability of the muscle membrane, possibly genetic in origin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17722048     DOI: 10.1002/mus.20865

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

1.  Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.

Authors:  S Veronica Tan; Emma Matthews; Melissa Barber; James A Burge; Sanjeev Rajakulendran; Doreen Fialho; Richa Sud; Andrea Haworth; Martin Koltzenburg; Michael G Hanna
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

Review 2.  Channelopathies of skeletal muscle excitability.

Authors:  Stephen C Cannon
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

3.  Genetic spectrum and founder effect of non-dystrophic myotonia: a Japanese case series study.

Authors:  Jun-Hui Yuan; Yujiro Higuchi; Akihiro Hashiguchi; Masahiro Ando; Akiko Yoshimura; Tomonori Nakamura; Yusuke Sakiyama; Hiroshi Takashima
Journal:  J Neurol       Date:  2022-07-30       Impact factor: 6.682

Review 4.  Thyrotoxic periodic paralysis: clinical and molecular aspects.

Authors:  Henrik Falhammar; Marja Thorén; Jan Calissendorff
Journal:  Endocrine       Date:  2012-08-24       Impact factor: 3.633

Review 5.  Treatment of neuromuscular channelopathies: current concepts and future prospects.

Authors:  James C Cleland; Robert C Griggs
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.